[1]马波,吴新华,罗敏.前房注射头孢呋辛预防白内障术后眼内炎的临床效果[J].眼科新进展,2016,36(7):637-639.[doi:10.13389/j.cnki.rao.2016.0169]
　MA Bo,WU Xin-Hua,LUO Min.Evaluation of intracameral cefuroxime injection for endophthalmitis prophylaxis following cataract surgery[J].Recent Advances in Ophthalmology,2016,36(7):637-639.[doi:10.13389/j.cnki.rao.2016.0169]
点击复制

前房注射头孢呋辛预防白内障术后眼内炎的临床效果
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
36卷
期数:
2016年7期
页码:
637-639
栏目:
应用研究
出版日期:
2016-07-05

文章信息/Info

Title:
Evaluation of intracameral cefuroxime injection for endophthalmitis prophylaxis following cataract surgery
作者:
马波; 吴新华; 罗敏
200011　上海市，上海交通大学医学院附属第九人民医院眼科
Author(s):
MA Bo; WU Xin-Hua; LUO Min
Department of Ophthalmology , Shanghai Ninth People ’ s Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200011 . China
关键词:
前房注射; 头孢呋辛; 白内障手术; 眼内炎
Keywords:
intracameral injection ;  cefuroxime ;  cataract surgery ;  endophthalmitis
分类号:
Ｒ７７１
DOI:
10.13389/j.cnki.rao.2016.0169
文献标志码:
A
摘要:
目的　探讨白内障术末前房注射头孢呋辛对眼内炎发生率的影响，评价该预防措施的临床效果。方法　回顾性研究２００９－２０１５年在我科接受白内障手术的１０５１５眼患者资料，统计各年份白内障患者中接受前房注射头孢呋辛的比例、眼内炎的发生率及逐年累积发生率。对术后眼内炎患者的年龄、性别、视力、病原菌及接受注射的情况进行分析。结果　过去７ａ接受白内障手术者５９９５例（１０５１５眼），其中９３８２眼（８９．２％）接受了前房注射头孢呋辛１ｍｇ／０．１ｍＬ。随着头孢呋辛前房注射比例的增加，感染性眼内炎发生率由０．１８２％（２００９年）降至０．０７２％（２０１１年），７ａ总体累积发生率为０．０３８％（９５％ ＣＩ，０．００１－０．０７５）。２００９－２０１１年白内障术后发生眼内炎４例，平均潜伏期３．７５ｄ。２０１２－２０１５年无眼内炎病例发生。所有接受注射的患者未发生药物毒性及过敏反应。结论　白内障术末前房注射１ｍｇ／０．１ｍＬ头孢呋辛安全有效，术后眼内炎的发生率明显降低，有望作为白内障围手术期预防感染的常规措施。
Abstract:
Objective To evaluate postoperative endophthalmitis incidence after adoption of intracameral cefuroxime injection following cataract surgery in ophthalmology department. Methods This was a retrospective clinical study. The electronic medical records were reviewed for 10 515 eyes with cataract surgeries in our department from 2009 t0 2015. The intracameral injection percentage and incidence of endophthalmitis for each year were calculated. Data of each patient with postoperative endophthalmitis were collected. Results A total number of 10 515 eyes of 5995 patients with cataract surgeries were evaluated over the past 7 years. Among them, 9382 eyes ( 89. 2% ) received intracameral cefuroxime injection( I m~0. I mL) . With the increase of injection cases, the incidence of endophthalmitis deceased from 0. 182% in 2009 to 0. 072% in 2011. The cumulative incidence of postoperative endopthalmitis was 0. 038% (95% CI.O. 001 - 0. 075 ) . Four cases of endophthalmitis after cataract surgery were identified and the mean onset time was 3. 75 days from 2009 t0 2011. No postoperative endophthalmitis case occurred from 2012 t0 2015. No severe complication was reported with application of prophylaxis measure. Conclusion With the safe and increasing use of intracameral cefuroxime ( I mg/0. I mL) , the incidence of postoperative endophthalmitis in our department is obviously low. It can be considered as an effective strategy for the control of postoperative endophthalmitis.

相似文献/References:

[1]曾庆延 蒋华 吴尚操 金晓丽.两性霉素B角膜基质和前房内注射治疗真菌性角膜脓肿[J].眼科新进展,2012,32(4):000.
[2]魏红领,刘韶瑞,刘泗容. 前房注射衣霉素建立大白兔慢性青光眼模型[J].眼科新进展,2015,35(7):629.[doi:10.13389/j.cnki.rao.2015.0171]
　WEI Hong-Ling,LIU Shao-Rui,LIU Si-Rong. Establishment of chronic glaucoma rabbit model by injecting tunicamycin to anterior chamber[J].Recent Advances in Ophthalmology,2015,35(7):629.[doi:10.13389/j.cnki.rao.2015.0171]
[3]付维,樊芳,贾志旸.白内障术后眼内炎药物预防研究进展[J].眼科新进展,2018,38(12):1180.[doi:10.13389/j.cnki.rao.2018.0279]
　FU Wei,FAN Fang,JIA Zhi-Yang.Advances in the prevention of endophthalmitis after cataract surgery[J].Recent Advances in Ophthalmology,2018,38(7):1180.[doi:10.13389/j.cnki.rao.2018.0279]
[4]王玉倩,黄钰森.白内障超声乳化术中灌注液加入头孢呋辛对房水细菌污染的控制作用[J].眼科新进展,2019,39(8):749.[doi:10.13389/j.cnki.rao.2019.0171]
　WANG Yu-Qian,HUANG Yu-Sen.Control actions of intraoperative cefuroxime in irrigating solutions on aqueous humor contamination after phacoemulsification of cataract[J].Recent Advances in Ophthalmology,2019,39(7):749.[doi:10.13389/j.cnki.rao.2019.0171]

备注/Memo

备注/Memo:
国家自然科学基金资助（编号：８１３００７７３）
更新日期/Last Update: 2016-07-12